News

Good prospects for the future

Read about the progress we have made and the milestones we have reached, about our growth and our experts, about our commitment and our communication, in short: everything that concerns us.
07/2020

First trends confirm: Bioelectronic stimulation method opens up new paths for epilepsy patients

Epilepsy is one of the most common chronic neurological disease patterns and is associated with a high degree of impairment of quality of life. Despite a […]
12/2019

Clinical phase: First expectations fulfilled

An innovative treatment for drug-refractory epilepsy is being tested in a European multicentre study. The pathway to a correct diagnosis in epilepsy patients is often very […]
05/2019
PRESS:

A promising treatment option from the perspective of doctors and patients

Innovative neurostimulation method persuasive among the first focal epilepsy patients  Basel/Heidelberg, May 24, 2019 – Some 30% of all epilepsy patients cannot be treated satisfactorily despite […]
04/2019
PRESS:

New hope for pharmacoresistant focal epilepsy: EASEE® Neurostimulation – first ever implantation in Freiburg

Globally, epilepsy is one of the most common chronic neurological conditions and greatly limits the lives of those affected. Approximately every third patient is refractory to […]
10/2018
PRESS:

Go-ahead for the first human implant

EASEE®, the innovative brain stimulation system developed by Precisis AG, has successfully completed the preclinical trial phase. For the first time, patients suffering from focal epilepsy […]
10/2018
PRESS:

Precisis AG receives BMBF funding for “Individualised medical technology”

Precisis AG, together with the Department of Microsystems Engineering at the Albert-Ludwigs University Freiburg and the Epilepsy Centre at the Freiburg University Clinic, has initiated a […]